IGC Pharma, Inc. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
IGC Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • IGC Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • IGC Pharma, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • IGC Pharma, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • IGC Pharma, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • IGC Pharma, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $0 $0 Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $0 $0 Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $0 $0 Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $0 -$2K -100% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $2K +$2K Apr 1, 2018 Mar 31, 2019 10-K 2020-07-13
2017 $0 -$14.4K -100% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-14
2016 $14.4K +$13.9K +2392% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-21
2015 $579 -$4.58K -88.8% Apr 1, 2015 Mar 31, 2016 10-K 2017-07-14
2014 $5.16K +$5.16K Apr 1, 2014 Mar 31, 2015 10-K 2016-07-14
2013 $0 +$365K Apr 1, 2013 Mar 31, 2014 10-K 2015-07-14
2012 -$365K -$538K -311% Apr 1, 2012 Mar 31, 2013 10-K 2014-07-15
2011 $173K -$3.93M -95.8% Apr 1, 2011 Mar 31, 2012 10-K/A 2014-07-15
2010 $4.1M Apr 1, 2010 Mar 31, 2011 10-K 2012-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.